Herbal combination of Shilajit, Ashwagandha (Withania Somnifera) and Brahmi (Bacopa Monnieri) are supplements that could help in protecting against brain degenerative diseases and dementia like Alzheimer's disease (AD). Alzheimer's disease and other forms of dementia have strong genetic connection. They run in families. Anyone whose close blood relatives like parents, grand parents or siblings has or had Alzheimer's disease is at an increasing risk of developing these diseases themselves. This herbal combination could reduce the risk as far as possible. Take this herbal combo and you could be protecting yourself from brain degenerative diseases. This herbal combo also has many wonderful health benefits right from boosting libido to anti aging to anti cancer. If any of your near and dear ones are already afflicted with Alzheimer's disease you can try this herbal combo for them too. It is very beneficial in initial and mid- stages. This can be used as an adjuvant therapy - in addition to the medicines prescribed by the doctor. Shilajit, Ashwagandha and Brahmi could slow down the progression and decrease the severity. 

These herbs have been used in Ayurvedic (traditional Indian system of medicine) for hundreds of years. There ae thousands of research reports, laboratory studies and patents on Shilajit, Ashwagandha (Withania Somnifera) and Brahmi (Bacopa Monnieri) which can be searched at scholar.google.com
 
 
Shilajit  Shilajit is a multi mineral pitch found in Himalayan mountains. A powerful anti aging agent. Shilajit contains 85+ minerals in ionic form and fulvic acid. With increasing age the cell walls become thick and it becomes increasingly difficult for the minerals and vitamins to be transported deep into the cells. This means that our cells -including that of the brain are malnourished with increasing age. This is irrespective of the nutritious food, vitamin and mineral supplements we take. Fulvic acid in shilajit dilates the thick cell walls and transports the minerals deep into the cells. Our body and brain would be effectively protected against any kind of degenerative disease with good nutrition. 
Ashwagandha (Withania Somnifera) Ashwagandha is known botanicaly as Withania somnifera. It has proven memory boosting effects and is known to enhance mental stamina. It is considered to be superior to Ginkgo Biloba in it's memory boosting effects.
Brahmi (Bacopa Monnieri) Brahmi is known botanicaly as Bacopa monnieri. Brahmi significantly improves the cognitive ability including an accelerated rate of learning and enhanced memory. These effects are optimized after a 12 week period. Bacopa monniera extract was found to reduce beta amyloid deposits in mice with Alzheimer's disease. Taken regularly, Brahmi can drastically reduce the chances of developing AD.

Combination of above three herbs show surprising results in enhancing memory and cognition. There are several research studies done by different group of neuro scientists - in Germany, Australia and India which have confirmed that Shilajit, Brahmi and Withania Somnifera can benefit AD patients. Taken well in advance this herbal combination drastically reduces the chances of developing AD.

If your loved one afflicted with AD is on prescription medicine try these safe natural herbals. They can be taken safely along with any other medicines as prescribed by the doctor.  If any of your close blood relative has or had Alzheimer's disease it will be a prudent decision for yourself to take this herbal combination well in advance for protection. Currently a few multi national pharmaceutical companies are studying the active ingredients in Ashwagandha and Brahmi to isolate the molecules that help in amyloid plaque reduction. While it may be several years from now to for the final molecule to be marketed as a prescription drug the herbal extract which is classified as a food product can be taken for the benefits. 

We recommend that this herbal combination of Shilajit, Brahmi and Ashwagandha be taken by you if any of your blood relatives has Alzheimer's disease and you are above the age of 30 years. This herbal combination could reduce the chances of developing dementia. As you might be aware Alzheimer's disease is genetic and it runs in families. The actual path to Alzheimer's disease starts as early as 20 years before the clinical diagnosis. For example some might be clinically diagnosed to be afflicted with AD at the age of 65 years but the trigger and gradual brain degeneration might have started right from the age of 45 years itself. Short term memory loss, decrease in cognitive ability, inability to concentrate, dip in intelligence level etc. might have started well in advance though with lesser intensity. Please take the herbal combination. Order from us and we will have it delivered within 10 days. The herbs of Shilajit, Brahmi and Ashwagandha are like any other food products and are absolutely safe.
Interact with us/ Send us any queries on facebook at   facebook.com/alzheimers.prevention.foods
Shilajit, Ashwagandha & Brahmi are classified as food Products/ Dietary supplements. ABSOLUTELY NO SIDE EFFECTS. They can be taken by anyone. We are an US FDA registered food facility.
 



 
Paul Flechsig Institute of Brain Research, Department of Neurochemistry, University of Leipzig, D-04109 Leipzig, Germany.

Following is the details of the research done by Scientists Schliebs R. Liebmann, and Volkr. Bigl at Paul Flechsig Institute Brain Res., Department of Neurochemistry, University of Leipzig, D-04109 Leipzig, Germany. Paul Flechsig Institute for Brain Research, Department of Neurochemistry, University of Leipzig, Germany - Cognition enhancing and memory improving effects Shilajit and the defined extract from Withania somnifera.  www.ncbi.nlm.nih.gov/pubmed/9017665
 
 

Summary: Systemic administration of Shilajit & Withania Somnifera enhances cognition and memory in Alzheimer's patients
 
 
 

 " Although some promising results have been achieved by acetyl cholinesterase inhibitors, an effective therapeutic intervention in Alzheimer's disease still remains an important goal. Withania somnifera as well as SHILAJIT, a pale brown to blackish brown exudation from steep rocks of the Himalayan mountain, are used in Indian Ayurvedic medical system to alleviate cerebral functional deficits including amnesia (memory loss) in geriatric patients. The present investigation was conducted to assess whether the memory enhancing effects of plant extracts from Withania somnifera and Shilajit are owing to neuro chemical alterations of specific transmitter systems. Therefore, histochemistry to analyze acetyl cholinesterase activity was performed in brain slices from adult male Wistar rats. Alzheimer's disease induced rats were injected intraperitoneally daily with Withaferin-A (prepared from Withania somnifera) and with Shilajit at doses of 40 mg/kg of body weight for 7 days. Administration of Withaferin and Shilajit led to reduced acetyl cholinesterase (AChE) staining thereby increasing it's levels. Acetyl Cholinesterase is an important neurotransmitter and it's levels are an important indicator of cognition and memory. Lower levels indicate brain degeneration, dementia and AD. The data suggest that Shilajit and the defined extract from Withania somnifera affect preferentially events in the cortical and basal forebrain cholinergic signal transduction cascade. The increase in cortical muscarinic Acetylcholine receptor capacity might partly explain the cognition enhancing and memory improving effects of extracts from Withania somnifera and shilajit observed in animals and humans.
 
 
 
National Brain Research Center, Government of India
 


Researchers at the National Brain Research Center, (NBRC) a nodal center under Department of Biotechnology of the Ministry of Science and Technology, Government of India seem to be close to success in finding some sort of cure to Alzheimer's disease. Working on mice with Alzheimer's disease with extracts of Ashwagandha – Withania Somnifera they reported promising results. National Brain Research Center neuro scientists tested extracts of Ashwagandha (Withania Somnifera) herb on two sets of test mice- one aged 10 months and the other aged 24 months. These mice were genetically altered to induce Alzheimer's disease. The mice were given oral extracts of Withania Somnifera for 30 days and monitored. Over the month the scientists found a reduction in amyloid plaques in mice brains (amyloid plaques in the brain are the major symptoms of Alzheimer's disease). The mice also exhibited significant improvement in their cognitive abilities. This study has been published in the proceedings of National Academy Of sciences. Consistent results could make Ashwagandha as a herb that offers a cure for Alzheimer's disease.
 

The wikipedia page on Ashwagandha http://en.wikipedia.org/wiki/Withania_somnifera
More on anti Alzheimer's properties of Shilajit (Fulvic acid) and Withania Somnifera
  

1. International Center for Biomedicine (ICC),  - Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. Shilajit contains 60% Fulvic acid in natural form .   www.ncbi.nlm.nih.gov/pubmed/21785188

2. Paul Flechsig Institute for Brain Research, Department of Neurochemistry, University of Leipzig, Germany - Cognition enhancing and memory improving effects Shilajit and the defined extract from Withania somnifera. www.ncbi.nlm.nih.gov/pubmed/9017665

3. More research reports on the beneficial effects of Withania Somnifera on Alzheimer's disease. Withania Somnifera (Ashwagandha) and Alzheimer's disease
 



 
 
Brain Sciences Institute, Swinburne University - Australia 
 
Brain & Psychological Sciences Research Cen.
Hawthorn VIC 3122, Australia
Ph: +61 3 9214 4361
bpsyc@swin.edu.au

For thousands of years Ayurvedic practitioners in India have used an aquatic plant known as Brahmi (Bacopa monniera) to enhance intelligence and mental functioning. Now, Western medicine is examining the herb’s potential to delay or treat dementia. Brahmi shows therapeutic effects that may help treat various symptoms related to Alzheimer's dementia, including loss of memory, capacity to learn, depression and anxiety.

Research & trials at Swinburne University of Technology's Brain Sciences Institute (funded by Australian Government) established scientific validity of Brahmi (Bacopa monnieri ) for the  prevention and treatment of Alzheimer's and dementia. Swinburne’s Professor Dr.Con Stough is the director of the NICM Collaborative Center for Natural Medicines and Neurocognition, which is responsible for a range of trials to improve the research behind alternative medicines. Other collaborators in the neurocognition research are the University of Western Australia, Melbourne's Alfred Hospital and CDR Australia. Two Brahmi trials have been done over 90  days with double-blind, randomized control techniques using a special brahmi extract. The results have shown improvements in working memory, particularly spatial memory accuracy.

Source: Wikipedia (http://en.wikipedia.org/wiki/Bacopa_monnieri). Laboratory studies on rats indicate that extracts of the Brahmi plant improves memory capacity. Recent studies suggest that Brahmi may improve intellectual activity. The sulfhydryl and polyphenol components of Brahmi extract have also been shown to impact the oxidative stress cascade by scavenging reactive oxygen species, inhibiting lipoxygenase activity and reducing divalent metals. This mechanism of action may explain the effect of Brahmi extract in reducing beta amyloid deposits in mice with Alzheimer's disease. In a study conducted on rats (J. Ethnopharmacol, 2009), a model was conducted where Alzheimer's disease is induced to rats. The rats were afterwards given Brahmi extract to determine its effects against Alzheimer's disease. The test showed that rats given a dose of up to 80 mg/kg of Brahmi extract had improved cognitive capability and mitigated the further reduction of brain neurons. Brahmi could increase the quality of life of AD patients to a very high degree though it remains to be seen if Brahmi could offer a cure for Alzheimer's disease. Taken well in advance Brahmi might help prevent/delay Alzheimer's disease.
 
  

The wikipedia page on Brahmi - Bacopa Monnieri  http://en.wikipedia.org/wiki/Bacopa_monnieri

Research report on Brahmi - Bacopa Monnieri     Southern Cross University, NSW, Australia

More research reports on the beneficial effects of Brahmi- Bacopa Monnieri on Alzheimer's disease 
                                                                     Bacopa Monnieri (Brahmi) and Alzheimer's disease



We welcome you to try Shilajit, Ashwagandha & Brahmi combination for any of your near and dear ones who may be afflicted with Alzheimer's disease. It could be beneficial in all stages. If you are above 30 years of age we strongly recommend this herbal combination to act as a preventive medicine against AD and maintain healthy brain function. This herbal formulation apart from offering a very powerful protection against Alzheimer's' disease has hundreds of other beneficial properties.

Order 1 Months' course Automatic Reorder 

Note: Currently we do not deliver to whole of Africa (Except Algeria, Morocco, Tunisia and Egypt) , Russian Federation, former CIS nations, Sweden, Denmark, Finland and Norway. Delivery is normally done within 12 days from the date of ordering. If you are ordering from Australia & New Zealand please allow 3-4 days extra time. 
 

Automatic monthly reorder One set of Anti Alzheimer's herbs will be shipped to your address automatically. You can cancel this automatic reorder provision anytime you want. 
U.S.$27 (All inclusive. Free shipping worldwide. Delivered within 12 days)

Instructions: The herbal extracts will be in capsule form. They can be taken along with water or milk. They instantly dissolve in water/juice or milk.

Interact with us/ Send us any queries on facebook at   facebook.com/alzheimers.prevention.foods

 
 
Credit  Card  Processor/online Retailer
2C0 Inc. 
1785 O'Brien Road
Columbus, OH-43228
USA
Physical  Shipping  by :
RELAXON 
An  United  States  FDA  Registered  Food  Facility 
US  FDA  Registration  Number :    14801626892
Alzheimer's Herbs ©  1999-2014 
Andy Kahn